Your browser doesn't support javascript.
loading
Impact of functional disability on health-care use and medical costs among cancer survivors.
Tak, Hyo Jung; Horner, Ronnie D; Lee, Min Sok; Shih, Ya-Chen Tina.
Afiliação
  • Tak HJ; Department of Health Services Research and Administration, University of Nebraska Medical Center, Omaha, NE, USA.
  • Horner RD; Department of Health Services Research and Administration, University of Nebraska Medical Center, Omaha, NE, USA.
  • Lee MS; Department of Economics, University of Chicago, Chicago, IL, USA.
  • Shih YT; Jonsson Comprehensive Cancer Center and Department of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
JNCI Cancer Spectr ; 7(5)2023 08 31.
Article em En | MEDLINE | ID: mdl-37584678
ABSTRACT

BACKGROUND:

Cancer survivors with a disability are among the most vulnerable in health status and financial hardship, but no prior research has systematically examined how disability modifies health-care use and costs. This study examined the association between functional disability among cancer survivors and their health-care utilization and medical costs.

METHODS:

We generated nationally representative estimates using the 2015-2019 Medical Expenditure Panel Survey. Outcomes included use of 6 service types (inpatient, outpatient, office-based physician, office-based nonphysician, emergency department, and prescription) and medical costs of aggregate services and by each of 6 service types. The primary independent variable was a categorical variable for the total number of functional disabilities. We employed multivariable generalized linear models and 2-part models, adjusting for sociodemographics and health conditions and accounting for survey design.

RESULTS:

Among cancer survivors (n = 9359; weighted n = 21 046 285), 38.8% reported at least 1 disability. Compared with individuals without a disability, cancer survivors with 4 or more disabilities experienced longer hospital stays (adjusted average marginal effect = 1.14 days, 95% confidence interval [CI] = 0.55 to 1.73), more visits to an office-based physician (average marginal effect = 1.43 visits, 95% CI = 0.51 to 2.35), and a greater number of prescriptions (average marginal effect = 12.1 prescriptions, 95% CI = 9.27 to 15.0). Their total (average marginal effect = $9537, 95% CI = $5713 to $13 361) and out-of-pocket (average marginal effect = $639, 95% CI = $79 to $1199) medical costs for aggregate services were statistically significantly higher. By type, disability in independent living was most strongly associated with greater costs for aggregate services.

CONCLUSIONS:

Cancer survivors with a disability experienced greater health-care use and higher costs. Cancer survivorship planning for health care and financial stability should consider the patients' disability profile.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: JNCI Cancer Spectr Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: JNCI Cancer Spectr Ano de publicação: 2023 Tipo de documento: Article